Benzinga | Feb 3, 2021 10:04AM EST

Credit Suisse Maintains Outperform on HCA Healthcare, Raises Price Target to $201

Credit Suisse analyst A.J. Rice maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $197 to $201.